OrganizationsSynthetic Biologics

Products 1 to 2 of 2

SYN-004 (RIBAXAMASE) by Synthetic Biologics
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 12,467,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: SynBio Database
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product
SYN-005 by Synthetic Biologics + Intrexon
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:27 (6 years ago)
Known funding amount: 24,800,000 USD
Funding types: Shareholder Investment
Industry: Health
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: SYN (NYSEMKT)
Value chain stage: Finished Product